• Home
  • About
  • Clinical
  • Authors
  • Most read this year
  • GP Opinion
  • Videos & Podcasts
  • Professional
  • Comments policy
  • RACGP
  • poll
Menu

Filter
‘A major public health crisis’: Diabetes policy under scrutiny

‘A major public health crisis’: Diabetes policy under scrutiny

Could a new Parliamentary Inquiry help address gaps in knowledge about the disease, as well as improve policy?


Lower birthweight an independent risk factor for T2D: Study

Lower birthweight an independent risk factor for T2D: Study

It is also linked to diagnosis at a younger age, a lower prevalence of overweight/obesity, and fewer family members with a history of diabetes.


RACGP opposes GLP-1 RA prescribing restrictions

RACGP opposes GLP-1 RA prescribing restrictions

Changing the authority type for initiating the diabetes medication will make it difficult for ‘already burdened’ GPs to negotiate, the PBS has been told.


GLP-1 RA prescribing checks flagged

GLP-1 RA prescribing checks flagged

GPs may soon need Services Australia approval prior to prescribing the diabetes medications, following evidence of ‘high use’ outside of PBS restrictions.


Intermittent semaglutide availability until at least June

Intermittent semaglutide availability until at least June

Supply issues will remain while the medicine’s sponsor ‘continues to build stable stock supplies over coming weeks and months’.


In Practice: Managing tick-borne illnesses

In Practice: Managing tick-borne illnesses

The information is aimed to further support health professionals and patients to better understand tick-borne illness in Australia.


Extended PBS access to ‘important’ insulin drug

Extended PBS access to ‘important’ insulin drug

The Government is urging patients with type 1 diabetes to obtain a GP prescription by 1 April to ensure ongoing access to Fiasp.


Could screening vitamin C levels improve diabetes outcomes?

Could screening vitamin C levels improve diabetes outcomes?

According to new research, it may reduce the risk of disease-related complications. But a GP expert points to a more person-centred approach.


TGA warns of online semaglutide scams

TGA warns of online semaglutide scams

The medicines regulator has said scams include advertising offers being sent to GPs for distribution to patients.


Semaglutide supplies return to Australia ahead of schedule

Semaglutide supplies return to Australia ahead of schedule

Limited quantities of the medication will be available from late next week, the TGA has said, but GPs have been asked to not prescribe it off-label.


  • Previous
  • ...
  • 4
  • 5
  • 6
  • ...
  • Next
Pages: 6 of 14
RACGP newsGP ArticlesnewsGP

Terms and conditions | Privacy statement | RACGP | recruitGP | AJGP

© 2018 The Royal Australian College of General Practitioners (RACGP) ABN 34 000 223 807